ophthalmologytimes17h
Qlaris Bio announces positive data from 2 clinical trials investigating QLS-111 in patients with primary open angle glaucoma and ocular hypertension
QLS‑111 is a novel topical formulation using Qlaris Bio’s ATP-sensitive potassium channel modulator platform. QLS-111 lowers ...
Daily5d
Use of speculum not solely responsible for postoperative ptosis: Study
A recent study explored the potential relationship between the use of speculums during phacoemulsification surgery and the ...